• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prevention of cardiovascular disease: Much more is needed.

作者信息

De Backer Guy G

机构信息

Department of Public Health, Ghent University, Belgium.

出版信息

Eur J Prev Cardiol. 2018 Jul;25(10):1083-1086. doi: 10.1177/2047487318770297. Epub 2018 Apr 25.

DOI:10.1177/2047487318770297
PMID:29692207
Abstract
摘要

相似文献

1
Prevention of cardiovascular disease: Much more is needed.心血管疾病的预防：我们还需要做更多。
Eur J Prev Cardiol. 2018 Jul;25(10):1083-1086. doi: 10.1177/2047487318770297. Epub 2018 Apr 25.
2
[Status of cholesterol goal attainment for the primary and secondary prevention of atherosclerotic cardiovascular disease in dyslipidemia patients receiving lipid-lowering therapy: DYSIS-China subgroup analysis].[接受降脂治疗的血脂异常患者动脉粥样硬化性心血管疾病一级和二级预防中胆固醇目标达成情况：中国血脂异常防治研究（DYSIS-China）亚组分析]
Zhonghua Xin Xue Guan Bing Za Zhi. 2016 Aug 24;44(8):665-70. doi: 10.3760/cma.j.issn.0253-3758.2016.08.006.
3
Targeting LDL Cholesterol: Beyond Absolute Goals Toward Personalized Risk.靶向低密度脂蛋白胆固醇：超越绝对目标，迈向个性化风险评估。
Curr Cardiol Rep. 2017 Jun;19(6):52. doi: 10.1007/s11886-017-0858-6.
4
[LDL cholesterol control in patients with very high cardiovascular risk. A simplified algorithm for achieving LDL cholesterol goals "in two steps"].
Clin Investig Arterioscler. 2014 Sep-Oct;26(5):242-52. doi: 10.1016/j.arteri.2014.05.004. Epub 2014 Jul 19.
5
[Are therapeutic LDL goals justified? Controversies between the European and American guidelines].[治疗性低密度脂蛋白目标是否合理？欧美指南之间的争议]
Medwave. 2016 Dec 30;16(Suppl4):e6825. doi: 10.5867/medwave.2016.6825.
6
Cholesterol, not just cardiovascular risk, is important in deciding who should receive statin treatment.胆固醇不仅与心血管风险有关，对于决定哪些人应该接受他汀类药物治疗也很重要。
Eur Heart J. 2015 Nov 14;36(43):2975-83. doi: 10.1093/eurheartj/ehv340. Epub 2015 Aug 4.
7
A review of the clinical evidence related to early treatment of elevated LDL for cardiovascular primary prevention.一项关于心血管病一级预防中早期治疗升高的低密度脂蛋白相关临床证据的综述。
Evid Based Med. 2015 Oct;20(5):162-9. doi: 10.1136/ebmed-2015-110170. Epub 2015 Jul 14.
8
Attainment of low-density lipoprotein cholesterol target in the French general population according to levels of cardiovascular risk: Insights from the MONA LISA study.根据心血管风险水平评估，法国普通人群中低密度脂蛋白胆固醇目标的达标情况：MONA LISA 研究的结果。
Arch Cardiovasc Dis. 2013 Feb;106(2):93-102. doi: 10.1016/j.acvd.2012.11.003. Epub 2013 Jan 16.
9
Frequency of Attainment of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol Goals in Cardiovascular Clinical Practice (from the National Cardiovascular Data Registry PINNACLE Registry).心血管临床实践中低密度脂蛋白胆固醇和非高密度脂蛋白胆固醇目标的达成频率（来自国家心血管数据注册库PINNACLE注册研究）
Am J Cardiol. 2015 Aug 15;116(4):547-53. doi: 10.1016/j.amjcard.2015.05.011. Epub 2015 May 21.
10
Low-density lipoprotein cholesterol targeting: a continued controversy.
Angiology. 2014 Mar;65(3):263-4. doi: 10.1177/0003319713508641. Epub 2013 Oct 31.

引用本文的文献

1
Construction of point mutation rabbits using CRISPR/Cas9.利用 CRISPR/Cas9 构建点突变兔。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2021 Apr 25;50(2):229-238. doi: 10.3724/zdxbyxb-2021-0133.
2
Reduction of Cardio-Metabolic Risk and Body Weight through a Multiphasic Very-Low Calorie Ketogenic Diet Program in Women with Overweight/Obesity: A Study in a Real-World Setting.通过多相极低卡路里生酮饮食方案降低超重/肥胖女性的心血管代谢风险和体重：真实环境中的研究。
Nutrients. 2021 May 26;13(6):1804. doi: 10.3390/nu13061804.
3
Hypolipemiant Actions and Possible Cardioprotective Effects of Valine and Leucine: An Experimental Study.
缬氨酸和亮氨酸的降血脂作用及可能的心脏保护作用：一项实验研究
Medicina (Kaunas). 2021 Mar 5;57(3):239. doi: 10.3390/medicina57030239.
4
Heat therapy: mechanistic underpinnings and applications to cardiovascular health.热疗：机制基础及其在心血管健康中的应用。
J Appl Physiol (1985). 2021 Jun 1;130(6):1684-1704. doi: 10.1152/japplphysiol.00141.2020. Epub 2021 Apr 1.
5
Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination ( BB536, Red Yeast Rice Extract) (Randomized, Double-Blind, Placebo-Controlled Study).在中度高胆固醇血症患者中，氧化固醇与动脉粥样硬化生物标志物的相互作用，以及营养组合（ BB536、红曲米提取物）的影响（随机、双盲、安慰剂对照研究）。
Nutrients. 2021 Jan 28;13(2):427. doi: 10.3390/nu13020427.
6
Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study.营养疗法管理心血管风险 - 一种含有益生菌长双歧杆菌 BB536 和红曲米提取物的组合：一项随机、双盲、安慰剂对照研究的结果。
Nutr J. 2019 Feb 22;18(1):13. doi: 10.1186/s12937-019-0438-2.
7
Body fat estimates from bioelectrical impedance equations in cardiovascular risk assessment: The PREVEND cohort study.基于生物电阻抗方程的体脂估计在心血管风险评估中的应用：PREVEND 队列研究。
Eur J Prev Cardiol. 2019 Jun;26(9):905-916. doi: 10.1177/2047487319833283. Epub 2019 Feb 21.